Concepedia
Statistics
Publications
8
Citations
292
H-Index
Active since
1979
Affiliations
Bayer (Germany)(Current)
University of Wuppertal
I. Hillebrand is an author at Bayer (Germany) specializing in pharmacology, diabetes mellitus, and medicine.
Publications per year
1979–1988
The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man
I. Hillebrand, K. Boehme, G. Frank et al. · Research in Experimental Medicine · 1979 · 105 citations
Medicine, Endocrinology, Pharmacology +15
The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: Dose-time-response relationships in man
I. Hillebrand, K. Boehme, G. Frank et al. · Research in Experimental Medicine · 1979 · 60 citations
Medicine, Endocrinology, Pharmacology +16
The effect of newα-glucosidase inhibitors (BAY m 1099 and BAY o 1248) on meal-stimulated increases in glucose and insulin levels in man
I. Hillebrand, K. Boehme, K.‐H. Graefe et al. · Journal of Molecular Medicine · 1986 · 26 citations
Medicine, Endocrinology, Pharmacology +12
The effect of a 1-deoxynojirimycin derivative on post-prandial blood glucose and insulin levels in healthy black and white volunteers
P. H. Joubert, C. P. Venter, H.F. Joubert et al. · European Journal of Clinical Pharmacology · 1985 · 24 citations
Medicine, Endocrinology, Pharmacology +5
A double-blind study on the efficacy and tolerance of a new alpha-glucosidase inhibitor in type-2 diabetics.
Nicholas Katsilambros, P Philippides, A. Toskas et al. · PubMed · 1986 · 22 citations
Medicine, Pharmacology, Pharmacotherapy +11
1–5 of 8